The International Symposium for Tissue Phenomics®

Discover a new perspective.

Breakthroughs in the fight against cancer come from seeing its full expression.

Why your peers are attending:

This is a must attend if you are passionate about translational immuno-oncology and learning how big data is shaping the field of precision oncology.

The Symposium has grown into a diverse event of  visionaries who drive the field in the early stages of discovery to transform healthcare through the integration of digital science and the world of Medical Big Data.

From biomarker discovery to commercialization, we help you see further.

HEAR

over 25+ global, industry leaders discuss…

CONNECT

with fellow drug discovery and development professionals from around the globe

SHARE

your Research by Presenting an abstract (and save $50!)

LEARN

about the expanding role of immunotherapy and big data.

What does digital healthcare mean for life sciences industry professionals?

How does it affect patients?

Why has it become such a hot topic?

The Symposium features industry leaders as they share their insights on the challenges and opportunities in this arena.

Integrating mobile health devices in clinical trials presents a wealth of opportunities for companies engaged in drug development. Digital health technologies – such as wearable opdevices, mobile applications, sensors and more – have the potential of revolutionizing clinical trials and natural history studies. Learn how these technologies can support real-time trial oversight and accurate, efficient and timely data capture.

Drawing from the cutting-edge work done by our member companies, panelists will share real-world examples of the opportunities and pitfalls presented when mobilizing clinical trials.

Featured
Speakers

BERNIE FOX
HEIKE GRABSCH
JAMES GULLEY
DIRK JAEGER
BAHIJA JALLAL
LAWRENCE WEISS
SIMONE BIANCO

The promise of immunotherapy can best be further optimized by understanding the complex interplay of host immune system and tumor and other cells in the tumor microenvironment.

James Gulley

The better understanding of tumor-host-interactions in the individual patient is becoming more and more relevant for individual treatment decisions.

Dirk Jaeger

This meeting addresses the most critical issue in oncology: understanding the complexity of individual tumors by applying complex technologies to tissues that preserve the molecular composition of cancer cells and, thus, truly represent the biological status of patients cancer.

Hartmut Juhl

I am thrilled to participate in this symposium. The breadth of topics and skills gathered by Dr Binnig and the organizer team sets an exemplary precedent for how research and communication in cancer pathology should be done in this century.

Simone Bianco

Rates

Academia

235

EARLY BIRD RATEOFFERED THROUGH 13 FEBRUARY, 2017

General Attendee

340

EARLY BIRD RATEOFFERED THROUGH 13 FEBRUARY, 2017

Academia

290

STANDARD RATEBEGINNING 14 FEBRUARY, 2017

General Attendee

425

STANDARD RATEBEGINNING 14 FEBRUARY, 2017

If you have any questions, please contact the Definiens Registration Team at 866-949-3408 or Definiens@unbridledsolutions.com.